about
In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle deliverySingle-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition.Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung.Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epitheliumSurface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissueDistribution of polymer nanoparticles by convection-enhanced delivery to brain tumors.Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir.Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer Therapy.From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection.Peptide Nucleic Acids as a Tool for Site-Specific Gene Editing.Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.In utero nanoparticle delivery for site-specific genome editing.Reply to Pandey et al.: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mouse model of HIV infectionStructural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIVFas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium
P50
Q30051830-09CDF0CC-693E-4332-8E30-EEABCC460686Q35097053-260F8B2E-7C61-4734-9A7E-51C3EDF69586Q35117840-DD17F4F5-CB78-4DD4-9C52-EA9382891B69Q35781735-35F6A4B2-0A42-4399-9042-2209FE274AA2Q36763633-88FAD7EB-EFE8-487F-A76D-658CF0BD33BFQ36881132-156D4E45-1085-416E-B74C-361B0179B7B6Q36971160-4D3B8552-03C8-4E96-8B54-86B39439D71EQ40075268-FE477D72-E2BF-4E5E-B983-B891DFF76DD9Q47119028-0E273760-4337-4A0D-A228-12BE10DE8AB9Q47217844-5288A634-78CD-4573-9F71-D2F387D87166Q52657758-E0C2FA82-BCE6-4E05-A6C9-D941E92DA15DQ52743737-235BB2EF-5095-4553-B151-C605DFDC494EQ55425649-C435D2E1-37C0-48A1-8720-050D9607EA68Q59354772-FD4D2636-54EC-4C7B-92E6-BC0D81D36E72Q91606964-59B3D367-40F7-425C-B046-3EF3E6E67542Q92131669-1C92F3A3-38F6-4B75-A965-E5C719116CA2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Elias Quijano
@ast
Elias Quijano
@en
Elias Quijano
@es
Elias Quijano
@nl
type
label
Elias Quijano
@ast
Elias Quijano
@en
Elias Quijano
@es
Elias Quijano
@nl
prefLabel
Elias Quijano
@ast
Elias Quijano
@en
Elias Quijano
@es
Elias Quijano
@nl
P106
P108
P31
P496
0000-0001-9747-4007